Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Long Zheng

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Blood|April 21, 2012
ADAMTS13 meets MR, then what?X Long Zheng
Blood|May 30, 2009
A team player: the disintegrin domain of ADAMTS13X Long Zheng
Journal of Thrombosis and Haemostasis : JTH|July 17, 2022
ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpuraKonstantine Halkidis, X Long Zheng
Annals of Blood|August 16, 2024
Animal models for thrombotic thrombocytopenic purpura: a narrative reviewLiang Zheng, X Long Zheng
Thrombosis and Haemostasis|May 13, 2021
Plasma Levels of Big Endothelin-1 Are Associated with Renal Insufficiency and In-Hospital Mortality of Immune Thrombotic Thrombocytopenic PurpuraRuinan Lu, X Long Zheng
Annals of Blood|May 18, 2023
How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?Lucy Zheng, X Long Zheng
Annals of Blood|August 5, 2024
Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative reviewSzumam Liu, X Long Zheng
Research and Practice in Thrombosis and Haemostasis|February 28, 2023
A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometryVikram G Pillai, X Long Zheng
Hereditary Genetics : Current Research|October 25, 2014
Current status in diagnosis and treatment of hereditary thrombotic thrombocytopenic purpuraHayley A Hanby, X Long Zheng
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2026
Hydrogen Exchange Mass Spectrometry (HX-MS) for Mapping Antibody Binding Sites and Conformational Dynamics of ADAMTS13Vikram G Pillai, X Long Zheng
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Blood|April 21, 2012
ADAMTS13 meets MR, then what?X Long Zheng
Blood|May 30, 2009
A team player: the disintegrin domain of ADAMTS13X Long Zheng
Journal of Thrombosis and Haemostasis : JTH|July 17, 2022
ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpuraKonstantine Halkidis, X Long Zheng
Annals of Blood|August 16, 2024
Animal models for thrombotic thrombocytopenic purpura: a narrative reviewLiang Zheng, X Long Zheng
Thrombosis and Haemostasis|May 13, 2021
Plasma Levels of Big Endothelin-1 Are Associated with Renal Insufficiency and In-Hospital Mortality of Immune Thrombotic Thrombocytopenic PurpuraRuinan Lu, X Long Zheng
Annals of Blood|May 18, 2023
How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?Lucy Zheng, X Long Zheng
Annals of Blood|August 5, 2024
Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative reviewSzumam Liu, X Long Zheng
Research and Practice in Thrombosis and Haemostasis|February 28, 2023
A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometryVikram G Pillai, X Long Zheng
Hereditary Genetics : Current Research|October 25, 2014
Current status in diagnosis and treatment of hereditary thrombotic thrombocytopenic purpuraHayley A Hanby, X Long Zheng
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2026
Hydrogen Exchange Mass Spectrometry (HX-MS) for Mapping Antibody Binding Sites and Conformational Dynamics of ADAMTS13Vikram G Pillai, X Long Zheng
Pageof 15